RYR1 and breast cancer: Namely, Lu et al. showed HIF-dependent expression of GSTO1-1 in breast cancer cells exposed to carboplatin with consequent breast cancer stem cell enrichment, mediated by interaction between GSTO1-1 and RyR1 and downstream activation of PYK2/SRC/STAT3 signaling [25].